The Q3 2021 quarterly report can be accessed using the link below
Learn MoreDedicated to the treatment of unmet medical needs in the field of fibrosis and rare orphan diseases
Learn MoreBrowse our resources hub for the latest news and information
Learn More
About us
Liminal BioSciences is a global clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases with a high unmet medical need. Our research program is focused on inflammatory, fibrotic and metabolic conditions in patients with liver, respiratory or renal disease, with an emphasis on rare or orphan diseases.
Product pipeline
Our expertise in small molecules has enabled a strong late-stage pipeline with potential best-in-class drugs.
Investors
Why Invest? Our world-class research and development team are constantly pushing boundaries to make discoveries which help the scientific community better understand rare disease and orphan drug development, especially effecting the liver, kidney and respiratory system.